Citation 1: Street MD, Donovan GR, Baldo BA, et al. Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence. Biochim Biophys Acta. 1996;1305(1-2):87-97. Published 1996 Feb 7. doi:10.1016/0167-4781(95)00197-2
Citation 2: Donovan GR, Street MD, Tetaz T, et al. Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products. Biochem Mol Biol Int. 1996;39(5):877-85. Published 1996 Aug. doi:10.1080/15216549600201022
Citation 3: Davies NW, Wiese MD, Brown SG, et al. Characterisation of major peptides in 'jack jumper' ant venom by mass spectrometry. Toxicon. 2004;43(2):173-83. Published 2004 Feb. doi:10.1016/j.toxicon.2003.11.021
Citation 4: Touchard A, Aili SR, Fox EG, et al. The Biochemical Toxin Arsenal from Ant Venoms. Toxins (Basel). 2016;8(1). Published 2016 Jan 20. doi:10.3390/toxins8010030
Citation 5: Nixon SA, Dekan Z, Robinson SD, et al. It Takes Two: Dimerization Is Essential for the Broad-Spectrum Predatory and Defensive Activities of the Venom Peptide Mp1a from the Jack Jumper Ant Myrmecia pilosula. Biomedicines. 2020;8(7). Published 2020 Jun 30. doi:10.3390/biomedicines8070185
Citation 6: Dekan Z, Headey SJ, Scanlon M, et al. Î-Myrtoxin-Mp1a is a Helical Heterodimer from the Venom of the Jack Jumper Ant that has Antimicrobial, Membrane-Disrupting, and Nociceptive Activities. Angew Chem Int Ed Engl. 2017;56(29):8495-8499. Published 2017 Jul 10. doi:10.1002/anie.201703360